No Data
No Data
CorMedix Inc. to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 25, 2025
Truist Financial Maintains CorMedix(CRMD.US) With Buy Rating
CORMEDIX INC. TO REPORT FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND PROVIDE A CORPORATE UPDATE ON MARCH 25, 2025
Truist Financial Remains a Buy on Cormedix (CRMD)
Li Auto, Xponential Fitness And Other Big Stocks Moving Lower In Friday's Pre-Market Session
$CRMD Stock Is up 9% Today. Here's What We See in Our Data.
White_Shadow :![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
lol. wgaf
Robert Musella OP White_Shadow : Ah, the keyboard warrior graces us with their wisdom. Don’t worry—your contribution will be remembered… just like every other irrelevant comment on the internet.
White_Shadow Robert Musella OP : i hear ya Robert Musella
Jeff Wong109 : tomorrow morning the stock market will be bloodbath, and you wii see a lot blood are running on street , Good luck for of you!!!!
Robert Musella OP Jeff Wong109 : Appreciate the warning, Jeff! Let’s see if the market survives the ‘bloodbath’—battle-hardened investors know to stay disciplined. Good luck to you too!